Guggenheim Capital LLC Beam Therapeutics Inc. Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 42,645 shares of BEAM stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
42,645
Previous 47,079 9.42%
Holding current value
$1.08 Million
Previous $1.1 Million 5.35%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$22.57 - $33.14 $100,075 - $146,942
-4,434 Reduced 9.42%
42,645 $1.04 Million
Q2 2024

Aug 14, 2024
SELL
$21.22 - $32.66 $27,925 - $42,980
-1,316 Reduced 2.72%
47,079 $1.1 Million
Q1 2024

May 14, 2024
SELL
$23.46 - $45.07 $75,259 - $144,584
-3,208 Reduced 6.22%
48,395 $1.6 Million
Q4 2023

Feb 14, 2024
SELL
$17.69 - $30.76 $325,319 - $565,676
-18,390 Reduced 26.27%
51,603 $1.4 Million
Q3 2023

Nov 14, 2023
SELL
$23.01 - $32.46 $376,190 - $530,688
-16,349 Reduced 18.94%
69,993 $1.68 Million
Q2 2023

Aug 11, 2023
BUY
$29.32 - $35.99 $149,649 - $183,692
5,104 Added 6.28%
86,342 $2.76 Million
Q1 2023

May 10, 2023
SELL
$30.15 - $48.79 $199,593 - $322,989
-6,620 Reduced 7.53%
81,238 $2.49 Million
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $12,047 - $16,924
328 Added 0.37%
87,858 $3.44 Million
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $374,384 - $661,546
-9,409 Reduced 9.71%
87,530 $4.17 Million
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $167,305 - $349,403
5,603 Added 6.13%
96,939 $3.75 Million
Q1 2022

May 16, 2022
BUY
$53.73 - $82.16 $117,238 - $179,273
2,182 Added 2.45%
91,336 $5.23 Million
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $1.15 Million - $1.67 Million
16,846 Added 23.3%
89,154 $7.1 Million
Q3 2021

Nov 15, 2021
BUY
$84.37 - $133.6 $4 Million - $6.34 Million
47,463 Added 191.04%
72,308 $6.29 Million
Q2 2021

Aug 13, 2021
BUY
$64.12 - $128.71 $1.59 Million - $3.2 Million
24,845 New
24,845 $3.2 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email